Atropine 0.01%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Atropine 0.01%, covering 2025-05-18 to 2025-05-18. Get the full timeline:
Most recent: Clinical Trial Update: The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3) [Phase 3]